BRI Biopharmaceutical Research Inc. is a preclinical drug development CRO specializing in analytical and bioanalytical chemistry with a focus on integrating all phases of preclinical drug-candidate development. Operating within a strict GLP environment, we perform comprehensive studies in support of all areas of preclinical and clinical drug development including lead drug candidate ADME selection, CMC studies, TK / PK studies, formulation development, bioanalytical method development and validation in support of clinical studies and natural health product development.

BRI recognizes that meeting today’s accelerated drug development timelines requires a unique design for each individual project, and our extensive expertise allows us to create customized solutions for drug development programs. Examples of customized solutions may have included hand filling of pilot batches of capsules for preclinical studies, trouble-shooting low oral bioavailability, or designing and supplying clinical sample collection and shipping kits for multi-clinical sites worldwide.

From drug discovery to IND submission to clinical trials, our accomplished staff along with our industry alliances are designing creative solutions for BRI to manage and offer a fully integrated preclinical drug product development program.